Home › Marginal Zone Lymphoma › Colorado › Denver
Marginal Zone Lymphoma clinical trials in Denver, CO
7 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Columbus, OH8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Nashville, TN7 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Multiple Myeloma27 studies
- Non-Small Cell Lung Cancer27 studies
- Colorectal Cancer23 studies
- Prostate Cancer19 studies
- Melanoma19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.